2006 Annual Meeting | Neurological Complications of Emerging Infections and Bioterrorism

Date Monday 04/03/06

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) Joseph R. Berger, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should become familiar with several infectious illnesses with neurological consequences that are emerging on the world stage and with biological and toxic weapons that have neurological consequences.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:30 PM - 07:00 PM		The Flu and von Economo's Encephalitis-Lessons from History Joseph R. Berger, MD, FAAN
06:30 PM - 09:30 PM		Dinner
07:00 PM - 07:00 PM		West Nile Virus Kenneth L. Tyler, MD, FAAN
07:30 PM - 08:00 PM		Nippah and Hendra Viruses Kenneth L. Tyler, MD, FAAN
08:00 PM - 08:30 PM		PML in the Era of Natalizumab Joseph R. Berger, MD, FAAN
08:30 PM - 08:45 PM		Break
08:45 PM - 09:00 PM		Weaponization of Biotoxins Jonathan Newmark, MD, MM, FAAN
09:00 PM - 09:30 PM		Chemical Agents of Neurological Interest Jonathan Newmark, MD, MM, FAAN

Faculty Disclosures
Jonathan Newmark, MD, MM, FAAN	Dr. Newmark has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Integrum BioSciences.
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Kenneth L. Tyler, MD, FAAN	Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.

��ɫ��

��ɫ��